VIRA-A Drug Patent Profile
✉ Email this page to a colleague
When do Vira-a patents expire, and what generic alternatives are available?
Vira-a is a drug marketed by Parkedale and is included in two NDAs.
The generic ingredient in VIRA-A is vidarabine. There are two drug master file entries for this compound. Additional details are available on the vidarabine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIRA-A?
- What are the global sales for VIRA-A?
- What is Average Wholesale Price for VIRA-A?
Summary for VIRA-A
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Patent Applications: | 6,409 |
| DailyMed Link: | VIRA-A at DailyMed |
US Patents and Regulatory Information for VIRA-A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parkedale | VIRA-A | vidarabine | INJECTABLE;INJECTION | 050523-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parkedale | VIRA-A | vidarabine | OINTMENT;OPHTHALMIC | 050486-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
